Table 2 M. tuberculosis study: validation results
From: Predicting bacterial resistance from whole-genome sequences using k-mers and stability selection
Stability | Mykrobe | ||||
|---|---|---|---|---|---|
R / S | sensi. | speci. | sensi. | speci. | |
ethambutol | 194 / 1391 | 60.3 (6.9) | 97.5 (0.8) | 71.6 (6.3) | 95.8 (1.1) |
isoniazid | 370 / 1216 | 89.7 (3.1) | 97.5 (0.9) | 84.3 (3.7) | 98.6 (0.7) |
kanamycin | 9 / 460 | 33.3 (30.8) | 98.9 (0.9) | 33.3 (30.8) | 99.6 (0.6) |
ofloxacin | 9 / 478 | 55.6 (32.5) | 99.6 (0.6) | 55.6 (32.5) | 100 (0) |
rifampicin | 303 / 1262 | 94.1 (2.7) | 99 (0.5) | 93.7 (2.7) | 99 (0.5) |
streptomycin | 353 / 1227 | 77.9 (4.3) | 99.1 (0.5) | 78.8 (4.3) | 99.3 (0.5) |